Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Annunziato Anghelone, Alessandro Strusi, Alessandro Scala, Martina Panebianco, Chiara Ciccarese & Roberto Iacovelli. (2023) 2023 ASCO genitourinary cancers symposium: focus on renal cell carcinoma. Expert Review of Anticancer Therapy 23:7, pages 669-672.
Read now
Read now
Susanna Gallo, Dario Sangiolo, Fabrizio Carnevale Schianca, Massimo Aglietta & Filippo Montemurro. (2017) Treating breast cancer with cell-based approaches: an overview. Expert Opinion on Biological Therapy 17:10, pages 1255-1264.
Read now
Read now
C Ciccarese, S Alfieri, M Santoni, D Santini, M Brunelli, C Bergamini, L Licitra, R Montironi, G Tortora & F Massari. (2016) New toxicity profile for novel immunotherapy agents: focus on immune-checkpoint inhibitors. Expert Opinion on Drug Metabolism & Toxicology 12:1, pages 57-75.
Read now
Read now
Articles from other publishers (17)
Margarita Y Gaas, Andrey D Kaprin, Nikolay V Vorobyev, Leonid M Rapoport, Dmitry O Korolev & Alexey S Kalpinsky. (2022) Markers of local kidney cancer recurrence: A surgeon’s mistake or a pattern? Review. Urologia Journal 90:3, pages 459-469.
Crossref
Crossref
Edwin Roger Parra, Jiexin Zhang, Mei Jiang, Auriole Tamegnon, Renganayaki Krishna Pandurengan, Carmen Behrens, Luisa Solis, Cara Haymaker, John Victor Heymach, Cesar Moran, Jack J. Lee, Don Gibbons & Ignacio Ivan Wistuba. (2023) Immune cellular patterns of distribution affect outcomes of patients with non-small cell lung cancer. Nature Communications 14:1.
Crossref
Crossref
Yuancheng Huang, Yushan Zou, Yanhua Tian, Zehong Yang, Zhengkun Hou, Peiwu Li, Fengbin Liu, Jiasheng Ling & Yi Wen. (2022) N6-methylandenosine-related immune genes correlate with prognosis and immune landscapes in gastric cancer. Frontiers in Oncology 12.
Crossref
Crossref
Hai Yao, Zhidong Cao, Haochuan Yong, Xiaoxing Zhang, Xin Zhang, Wei Li, Shenshen Zhi & Wenyan Wu. (2022) A Pan-Cancer Analysis on the Systematic Correlation of MutS Homolog 2 (MSH2) to a Malignant Tumor. Journal of Oncology 2022, pages 1-22.
Crossref
Crossref
Yuanxue Yi, Qiufang Zhang, Youfeng Shen, Yueyi Gao, Xiaohong Fan, Sini Chen, Xin Ye & Jian Xu. (2022) System Analysis of Adaptor-Related Protein Complex 1 Subunit Mu 2 (AP1M2) on Malignant Tumors: A Pan-Cancer Analysis. Journal of Oncology 2022, pages 1-17.
Crossref
Crossref
Amanda Guth, Emily Monk, Rajesh Agarwal, Bryan C. Bergman, Karin A. Zemski-Berry, Angela Minic, Kimberly Jordan & Isabel R. Schlaepfer. (2020) Targeting Fat Oxidation in Mouse Prostate Cancer Decreases Tumor Growth and Stimulates Anti-Cancer Immunity. International Journal of Molecular Sciences 21:24, pages 9660.
Crossref
Crossref
Yanwen Zhong, Xuanyi Li, Hequan Yao & Kejiang Lin. (2019) The Characteristics of PD-L1 Inhibitors, from Peptides to Small Molecules. Molecules 24:10, pages 1940.
Crossref
Crossref
Simon P. Hood, Gemma A. Foulds, Heather Imrie, Stephen Reeder, Stéphanie E. B. McArdle, Masood Khan & Alan Graham Pockley. (2019) Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation. Frontiers in Immunology 9.
Crossref
Crossref
Antonio Lopez-Beltran, Vanessa Henriques, Alessia Cimadamore, Matteo Santoni, Liang Cheng, Thomas Gevaert, Ana Blanca, Francesco Massari, Marina Scarpelli & Rodolfo Montironi. (2018) The Identification of Immunological Biomarkers in Kidney Cancers. Frontiers in Oncology 8.
Crossref
Crossref
Francesco Carrozza, Matteo Santoni, Francesco Piva, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, Rodolfo Montironi, Nicola Battelli & Stefano Tamberi. (2018) Emerging immunotherapeutic strategies targeting telomerases in genitourinary tumors. Critical Reviews in Oncology/Hematology 131, pages 1-6.
Crossref
Crossref
Edwin Roger Parra, Pamela Villalobos, Jiexin Zhang, Carmen Behrens, Barbara Mino, Stephen Swisher, Boris Sepesi, Annika Weissferdt, Neda Kalhor, John Victor Heymach, Cesar Moran, Jianjun Zhang, Jack Lee, Jaime Rodriguez-Canales, Don Gibbons & Ignacio I. Wistuba. (2018) Immunohistochemical and Image Analysis-Based Study Shows That Several Immune Checkpoints are Co-expressed in Non–Small Cell Lung Carcinoma Tumors. Journal of Thoracic Oncology 13:6, pages 779-791.
Crossref
Crossref
Atsunari Kawashima, Takayuki Kanazawa, Kumiko Goto, Mitsunobu Matsumoto, Akiko Morimoto-Okazawa, Kota Iwahori, Takeshi Ujike, Akira Nagahara, Kazutoshi Fujita, Motohide Uemura, Norio Nonomura & Hisashi Wada. (2017) Immunological classification of renal cell carcinoma patients based on phenotypic analysis of immune check-point molecules. Cancer Immunology, Immunotherapy 67:1, pages 113-125.
Crossref
Crossref
Chiara Ciccarese, Roberto Iacovelli, Emilio Bria, Alessandra Modena, Francesco Massari, Matteo Brunelli, Emanuela Fantinel, Davide Bimbatti, Giulia A Zamboni, Walter Artibani & Giampaolo Tortora. (2017) The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies. Immunotherapy 9:7, pages 579-587.
Crossref
Crossref
Roberto IacovelliChiara Ciccarese, Emanuela Fantinel, Davide Bimbatti, Mario Romano, Antonio Benito Porcaro, Salvatore Siracusano, Renzo Mazzarotto, Walter Artibani & Giampaolo Tortora. (2018) Renal Toxicity in Patients Treated with Anti-Pd-1 Targeted Agents for Solid Tumors. Journal of Onco-Nephrology 1:2, pages 132-142.
Crossref
Crossref
Anna Partyka, Krzysztof Tupikowski, Anna Kolodziej, Romuald Zdrojowy, Agnieszka Halon, Bartosz Malkiewicz, Janusz Dembowski, Irena Frydecka & Lidia Karabon. (2016) Association of 3′ nearby gene BTLA polymorphisms with the risk of renal cell carcinoma in the Polish population. Urologic Oncology: Seminars and Original Investigations 34:9, pages 419.e13-419.e19.
Crossref
Crossref
Matteo Santoni, Marina Scarpelli, Antonio Lopez-Beltran, Liang Cheng, Alberto Briganti, Francesco Montorsi, Rodolfo Montironi & Daniele Santini. (2016) Re: Idir Ouzaid and Karim Bensalah. Results of the First Trial Assessing Adjuvant Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Do Not reASSURE. Eur Urol 2015;68:542–3. European Urology 70:3, pages e69-e70.
Crossref
Crossref
MARIANNA LAURICELLA, DANIELA CARLISI, MICHELA GIULIANO, GIUSEPPE CALVARUSO, CESARE CERNIGLIARO, RENZA VENTO & ANTONELLA D'ANNEO. (2016) The analysis of estrogen receptor-α positive breast cancer stem-like cells unveils a high expression of the serpin proteinase inhibitor PI-9: Possible regulatory mechanisms. International Journal of Oncology 49:1, pages 352-360.
Crossref
Crossref